Sigma Aldrich Research Biochemicals, Inc. has applied to the Drug Enforcement Administration (DEA) to become registered as a bulk manufacturer of controlled substances. The public is invited to submit comments or objections and request a hearing by April 26, 2021. The application was submitted on December 17, 2020, and aims to manufacture reference standards of certain controlled substances. Comments should be sent to the DEA at the address provided in the notice.
Simple Explanation
Sigma Aldrich Research Biochemicals wants permission to make certain types of special medicines and is asking for public feedback by April 26, 2021. They need to follow the rules to make sure the medicines are handled safely, and people can ask questions or share their thoughts with the DEA.